文献检索，用中文搜 PubMed

1

Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease.撤回：依折麦布联合低至中等强度阿托伐他汀辅助阿司匹林治疗对脑血管疾病的影响。

Comput Math Methods Med. 2023 Aug 23;2023:9853760. doi: 10.1155/2023/9853760. eCollection 2023.

2

Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease.依折麦布联合低-中强度阿托伐他汀辅助阿司匹林治疗脑血管病的意义。

Comput Math Methods Med. 2022 Jul 18;2022:3369226. doi: 10.1155/2022/3369226. eCollection 2022.

3

Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study.冠状动脉血运重建术后中等强度他汀类药物联合依折麦布与高强度他汀类药物的比较：一项队列研究

Cardiovasc Drugs Ther. 2023 Feb;37(1):141-150. doi: 10.1007/s10557-021-07256-1. Epub 2021 Sep 17.

4

Effect of Atorvastatin (10 mg) and Ezetimibe (10 mg) Combination Compared to Atorvastatin (40 mg) Alone on Coronary Atherosclerosis.阿托伐他汀（10mg）和依折麦布（10mg）联合治疗与阿托伐他汀（40mg）单独治疗对冠状动脉粥样硬化的影响。

Am J Cardiol. 2021 Sep 1;154:22-28. doi: 10.1016/j.amjcard.2021.05.039. Epub 2021 Jul 6.

5

Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.依洛尤单抗或依折麦布联合中等强度或高强度他汀类药物治疗对高胆固醇血症患者 LDL-C 降低的影响：LAPLACE-2 随机临床试验。

JAMA. 2014 May 14;311(18):1870-82. doi: 10.1001/jama.2014.4030.

6

Comparing the combination therapy of ezetimibe and atorvastatin with atorvastatin monotherapy for regulating blood lipids: a systematic review and meta-analyse.比较依折麦布与阿托伐他汀联合治疗与阿托伐他汀单药治疗调节血脂的疗效：系统评价和荟萃分析。

Lipids Health Dis. 2018 Oct 17;17(1):239. doi: 10.1186/s12944-018-0880-8.

7

Hypolipidaemic and anti-inflammatory effects of fixed dose combination of atorvastatin plus ezetimibe in Indian patients with dyslipidaemia.固定剂量阿托伐他汀与依折麦布联合治疗血脂异常印度患者的调脂和抗炎作用。

Singapore Med J. 2013 Feb;54(2):90-5. doi: 10.11622/smedj.2013031.

8

Efficacy and Tolerability of Ezetimibe/Atorvastatin Fixed-dose Combination Versus Atorvastatin Monotherapy in Hypercholesterolemia: A Phase III, Randomized, Active-controlled Study in Chinese Patients.依泽替米贝/阿托伐他汀固定剂量复方制剂与阿托伐他汀单药治疗在中国高胆固醇血症患者中的疗效和耐受性：一项 III 期、随机、阳性对照研究。

Clin Ther. 2022 Oct;44(10):1282-1296. doi: 10.1016/j.clinthera.2022.08.013. Epub 2022 Sep 29.

9

Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?依折麦布联合低剂量阿托伐他汀治疗与单独使用高剂量阿托伐他汀治疗相比：足够的胆固醇降低幅度是否足以抑制血小板？

J Am Coll Cardiol. 2007 Mar 13;49(10):1035-42. doi: 10.1016/j.jacc.2006.10.064. Epub 2007 Feb 23.

10

Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia.比较依折麦布联合非诺贝特与阿托伐他汀单药治疗血脂异常的疗效。

Lipids Health Dis. 2009 Dec 17;8:56. doi: 10.1186/1476-511X-8-56.

Suppr 超能文献

文献检索

文件翻译

深度研究

Suppr 超能文献

文献检索

文件翻译

深度研究

撤回：依折麦布联合低至中等强度阿托伐他汀辅助阿司匹林治疗对脑血管疾病的影响。

Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease.

作者信息

出版信息

相似文献